SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-418755
Filing Date
2012-10-09
Accepted
2012-10-09 17:26:35
Documents
5
Period of Report
2012-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d421507d8k.htm 8-K 34296
2 ESCROW CORP INDENTURE d421507dex41.htm EX-4.1 693004
3 SUPPLEMENTAL INDENTURE TO THE ESCROW CORP INDENTURE d421507dex42.htm EX-4.2 65115
4 CONCURRENT INDENTURE d421507dex43.htm EX-4.3 726104
5 JOINDER AGREEMENT d421507dex101.htm EX-10.1 120690
  Complete submission text file 0001193125-12-418755.txt   1640678
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 121135921
SIC: 2834 Pharmaceutical Preparations